Great Tree Pharmacy Co., Ltd. Stocks

NT$ 77.8Last Updated 29.04.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

NT$ 372.17M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 77.8
Key Takeaways

Risk factor

Weak & very vulnerable to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Great Tree Pharmacy Co., Ltd. operates a chain of drug stores in Taiwan. Its stores offer medicines, health foods, maternal and child products, and cosmetics; and various types of coordinating procurement services for medicines in clinics, joint outpatient centers, and cluster medical communities, as well as agents of various clinics, joint outpatient centers, and cluster medical communities selling hot-selling domestic and foreign health products. The company was formerly known as Tianjin Pharmaceutical Co., Ltd. and changed its products to Great Tree Pharmacy Co., Ltd. Great Tree Pharmacy Co., Ltd. was founded in 2001 and is headquartered in Taoyuan City, Taiwan.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, u

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of 6469.TWO is 132 and suggests 69% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks